Evaluation of real‐time data obtained from gravimetric preparation of antineoplastic agents shows medication errors with possible critical therapeutic impact: Results of a large‐scale, multicentre, multinational, retrospective study
Terkola, R., Czejka, M., Bérubé, J.
Published in Journal of clinical pharmacy and therapeutics (01.08.2017)
Published in Journal of clinical pharmacy and therapeutics (01.08.2017)
Get full text
Journal Article
Multiple dose pharmacokinetics of erlotinib when combined with gastric acid reducing agents: A comparison with a physiologically based pharmacokinetic model
Hrgovcic, A. Sahmanovic, Gruber, A., Dittrich, C., Kitzmueller, M., Buchner, P., Baroian, N. Kirchbaumer, Czejka, M.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
P-139Monitoring of erlotinib plasma concentrations after long time administration of 100 mg in advanced pancreatic cancer patients
Sahmanovic, A, Buchner, P, Lichtneckert, M, Dittrich, C, Farkouh, A, Gruber, A, Baroian, N, Kitzmueller, M, Czejka, M
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
2098 Assessment of pharmacokinetic (PK) interaction between cetuximab (CTX) and capecitabine (CCB) or oxaliplatin (OX) in metastatic colorectal cancer (mCRC) patients (pts) (AGMT_CAPECET_PK)
Schreiber, V, Kitzmueller, M, Buchner, P, Weissenboeck, N, Lichtneckert, M, Greil, R, Geiler, H, Czejka, M, Dittrich, C
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Metabolic Activation of Irinotecan during Intra-arterial Chemotherapy of Metastatic Colorectal Cancer
CZEJKA, M, KISS, A, KOESSNER, C, TERKOLA, R, ETTLINGER, D, SCHUELLER, J
Published in Anticancer research (01.10.2011)
Get full text
Published in Anticancer research (01.10.2011)
Journal Article
Disposition of Erlotinib and Its Metabolite OSI420 in a Patient with High Bilirubin Levels
Czejka, M., Sahmanovic, A., Buchner, P., Steininger, T., Dittrich, C.
Published in Case reports in oncology (12.12.2013)
Published in Case reports in oncology (12.12.2013)
Get full text
Journal Article
Plasma disposition of capecitabine (CCB) and its metabolites 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouracil (5'-DFUR) with two different capecitabine/oxaliplatin dosage regimens
Farkouh, A, Schueller, J, Scheithauer, W, Czejka, M
Published in International journal of clinical pharmacology and therapeutics (01.07.2010)
Published in International journal of clinical pharmacology and therapeutics (01.07.2010)
Get more information
Journal Article
Evidence for the conversion of docetaxel into 7'-epidocetaxel in patients receiving Taxotere-based conventional chemotherapy
Czejka, M, Greil, R, Ulsperger, E, Schnait, H, Kienesberger, K, Brumnik, T, Farkouh, A, Schierholz, J
Published in International journal of clinical pharmacology and therapeutics (01.07.2010)
Published in International journal of clinical pharmacology and therapeutics (01.07.2010)
Get more information
Journal Article
Systemic side effects of eye drops: a pharmacokinetic perspective
Farkouh, Andre, Frigo, Peter, Czejka, Martin
Published in Clinical ophthalmology (Auckland, N.Z.) (01.01.2016)
Published in Clinical ophthalmology (Auckland, N.Z.) (01.01.2016)
Get full text
Journal Article
6090 Influence of Cetuximab applied as biweekly infusion on the plasma disposition of CPT 11 and its metabolites in advanced colorectal cancer
Schueller, J, Czejka, M, Kiss, A, Farkouh, A, Aigner, K, Krexner, E, Gruenberger, B
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
Disposition of paclitaxel (Taxol®) and its metabolites in patients with advanced breast cancer (ABC) when combined with trastuzumab (Hercpetin®)
FURTLEHNER, A, SCHUELLER, J, JARISCH, I, OSTERMANN, E, CZEJKA, M
Published in European journal of drug metabolism and pharmacokinetics (01.07.2005)
Published in European journal of drug metabolism and pharmacokinetics (01.07.2005)
Get full text
Journal Article
P-168Multiple dose pharmacokinetics of erlotinib when combined with gastric acid reducing agents: A comparison with a physiologically based pharmacokinetic model
Hrgovcic, A Sahmanovic, Gruber, A, Dittrich, C, Kitzmueller, M, Buchner, P, Baroian, N Kirchbaumer, Czejka, M
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Long-term pharmacokinetics of doxorubicin HCl stealth liposomes in patients after polychemotherapy with vinorelbine, cyclophosphamide and prednisone (CCVP)
LINKESCH, W, WEGER, M, EDER, I, AUNER, H. W, PERNEGG, C, KRAULE, C, CZEJKA, M. J
Published in European journal of drug metabolism and pharmacokinetics (01.07.2001)
Published in European journal of drug metabolism and pharmacokinetics (01.07.2001)
Get full text
Journal Article
P-139 Monitoring of erlotinib plasma concentrations after long time administration of 100 mg in advanced pancreatic cancer patients
Sahmanovic, A., Buchner, P., Lichtneckert, M., Dittrich, C., Farkouh, A., Gruber, A., Baroian, N., Kitzmueller, M., Czejka, M.
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
Clinical pharmacokinetics and metabolism of paclitaxel after polychemotherapy with the cytoprotective agent amifostine
Czejka, M, Schueller, J, Eder, I, Reznicek, G, Kraule, C, Zeleni, U, Freitag, R
Published in Anticancer research (01.09.2000)
Get more information
Published in Anticancer research (01.09.2000)
Journal Article
Phase Ib Trial to Evaluate Capecitabine (C), Erlotinib (E), and Bevacizumab (B) in Patients (Pts) with Unresectable and/or Metastatic Pancreatic Cancer (Umpc) – Preliminary Results of the Rebeca Trial Including Pharmacokinetics (Pk) and Circulating Tumor Cells (Ctcs)
Dittrich, C., Buchner, P., Sahmanovic, A., Königsberg, R., Lichtneckert, M., Nirnberger, G., Czejka, M., Geissler, K.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
701PPHASE IB TRIAL TO EVALUATE CAPECITABINE (C), ERLOTINIB (E), AND BEVACIZUMAB (B) IN PATIENTS (PTS) WITH UNRESECTABLE AND/OR METASTATIC PANCREATIC CANCER (UMPC) – PRELIMINARY RESULTS OF THE REBECA TRIAL INCLUDING PHARMACOKINETICS (PK) AND CIRCULATING TUMOR CELLS (CTCS)
Dittrich, C., Buchner, P., Sahmanovic, A., Königsberg, R., Lichtneckert, M., Nirnberger, G., Czejka, M., Geissler, K.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Influence of interferon alfa-2b with or without folinic acid on pharmacokinetics of fluorouracil
Schüller, J, Czejka, M J, Schernthaner, G, Fogl, U, Jäger, W, Micksche, M
Published in Seminars in oncology (01.04.1992)
Get more information
Published in Seminars in oncology (01.04.1992)
Journal Article
Disposition of 5-formyl- and 5-methyltetrahydrofolic acid in serum after i.v. bolus of calcium folinate: pharmacokinetic drug interaction with preadministered interferon-alpha-2b
Czejka, M J, Schüller, J, Weiss, C, Bandak, S, Meyer, B, Simon, D
Published in European journal of drug metabolism and pharmacokinetics (01.10.1995)
Published in European journal of drug metabolism and pharmacokinetics (01.10.1995)
Get more information
Journal Article